Peter Rose

Director/Board Member at Deltex Medical Ltd.

56 year

Health Technology

Distribution Services

Profile

Peter Kenneth Rose is currently a Director at Deltex Medical Ltd.
He previously worked as a Director-International Sales at Deltex Medical Group Plc.

Peter Rose active positions

Companies	Position	Start
Deltex Medical Ltd. Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears.	Director/Board Member	2010-03-29

All active positions of Peter Rose

Former positions of Peter Rose

Companies	Position	End
DELTEX MEDICAL GROUP PLC	Sales & Marketing	-

See the detail of Peter Rose's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Rose's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
DELTEX MEDICAL GROUP PLC	Health Technology

Private companies	1
Deltex Medical Ltd. Deltex Medical Ltd. Medical DistributorsDistribution Services Part of Deltex Medical Group Plc, Deltex Medical Ltd. is a British manufacturer of fluid management devices, including the CardioQ-ODM and CardioQ-ODM+. The company is based in Chichester, UK. The British company provides a single platform, TrueVue™ with ODM+, measuring flow and pressure directly, which includes Oesophageal Doppler Monitoring, Pulse Pressure Waveform Analysis (PPWA) & High Definition Impedance Cardiography (HD-ICG) in a single unit. Enhanced Recovery has evolved, requiring individualised goal directed haemodynamic therapy, optimised through cardiac output monitoring. TrueVue™ Loops plots aortic blood flow velocity and pressure, on every heartbeat, displaying it graphically, providing a complete haemodynamic picture, in real-time. The company was founded in 1992. The CEO is Andrew Jonathan Mears.	Distribution Services